Table 1.
Baseline characteristics of Multi-Ethnic Study of Atherosclerosis participants.
| Variable | < 7.5% cPCE (N=4185) | ≥ 7.5 cPCE (N=1,000) | Total Cohort (n=5185) |
|---|---|---|---|
| Age, yrs (Mean ± SD) | 58.2 ± 8.6 | 73.6 ± 6.6 | 61.2 ±10.3 |
| Females, n (%) | 2380(56.9) | 371(37.1) | 2751(53.1) |
| Race/Ethnicity (%) | |||
| Whites | 1606(38.4) | 363(36.3) | 1969(38) |
| Chinese | 518(12.4) | 107(10.7) | 625(12.1) |
| Black | 1117(26.7) | 285(28.5) | 1402(27.0) |
| Hispanic | 944(22.6) | 245(24.5) | 1189(22.9) |
| Diabetes mellitus, n (%) | 236 (5.6) | 270 (27.0) | 506(9.8) |
| Cholesterol, mg/dl (Mean ± SD ) | |||
| Total | 196.2 ± 35.1 | 197.2 ± 37.9 | 196.4 ±35.7 |
| LDL* | 119.3 ± 31.2 | 121.2 ± 32.0 | 119.7± 31.4 |
| HDL | 51.6 ± 15.0 | 48.4 ± 14.4 | 51.0 ±15.0 |
| Triglycerides | 126.6 ± 75.5 | 142.7 ± 125.8 | 129.7 ±87.7 |
| BMI, Kg/m2 (Mean ± SD) | 28.2 ± 5.6 | 28.0 ± 4.9 | 28.2 ±5.4 |
| Blood Pressure, mmHg (Mean ± SD) | |||
| Systolic | 121.0 ± 18.5 | 145.0 ± 21.9 | 125.6± 21.4 |
| Diastolic | 71.3 ± 10.1 | 75.1 ± 11.0 | 72.1 ±10.4 |
| Cigarette smoking, n (%) | |||
| Never | 2177(52.0) | 447(44.7) | 2624(50.6) |
| Former | 1457(34.8) | 397(44.7) | 1854(35.8) |
| Current | 551(13.2) | 156(15.6) | 707(13.6) |
| Antihypertensive medication use, n (%) | 1092(26.1) | 591(59.1) | 1683(32.5) |
| CAC >/= 300 or >/= 75 | 903 (21.6) | 346 (34.6) | 1249(24.1) |
| hsCRP >/= 2 mg/dl | 2004(47.9) | 506 (50.6) | 2510(48.4) |
| ABI < 0.9 | 63(1.5) | 94(9.4) | 157(3.0) |
| LDLc >/= 160 mg/dl | 401(9.7) | 108(11.0) | 509(9.9) |
| Family history | 1688(40.3) | 433(43.3) | 2121(40.9) |
Footnote: cPCE, calibrated Pooled Cohort Equation; ASCVD, atherosclerotic cardiovascular disease; MI, myocardial infarction; CAC, coronary artery calcium score; Hs-CRP, high sensitivity C-reactive protein; ABI, ankle brachial index; LDL, low density lipoprotein, HDL, high density lipoprotein; IQR, inter quartile range.
*
LDL sample size = 5123 (due to missing values)